T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 7.31 USD 0.07% Market Closed
Market Cap: 365.2m USD

EV/EBIT
Enterprise Value to EBIT

-12
Current
-5.7
Median
13.4
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-12
=
Enterprise Value
374.8m USD
/
EBIT
-31.3m USD
All Countries
Close
EBIT Growth EV/EBIT to Growth
US
T
TriSalus Life Sciences Inc
NASDAQ:TLSI
Average EV/EBIT: 950.3
Negative Multiple: -12
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
93%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
IN
S
SAB Industries Ltd
BSE:539112
61.5
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-1%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
Coupang Inc
F:788
53.6
78%
0.7
US
R
Reddit Inc
NYSE:RDDT
148.9
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -469.4 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-13.4
2-Years Forward
EV/EBIT
-79.6
3-Years Forward
EV/EBIT
27.6